Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

FDA Sets New Regulations for Breast Implant Manufacturers

December 10, 2021 By Law Offices of Thomas J. Lamb, P.A.

An October 2021 article, “FDA sets stronger safety warnings for breast implants“, addresses the Food and Drug Administration’s (FDA) new requirements for breast implant manufacturers. The new regulations will require patients receive detailed information about the potential risks and complications of implants prior to receiving surgery.

However, this is not the only change the FDA is requiring. In addition to the new regulations, breast implant manufacturers are now required to add a boxed warning message to the written patient materials.

New Regulations Laid Out By FDA

According to the same October 2021 article, “FDA sets stronger safety warnings for breast implants“, these regulations were proposed as voluntary back in 2019, but have only recently become requirements:

The FDA had originally proposed the rules as voluntary measures in 2019, but Wednesday’s action makes them legal requirements for breast implant makers, including leading manufacturers like Johnson & Johnson’s Mentor unit and Allergan.

In the biggest shift, plastic surgeons and other health professionals who work with the implants must give their patients a checklist detailing possible side effects, such as scarring, pain, rupture and even a rare form of cancer. The checklist also explains that breast implants often require repeat surgeries and they should not be considered lifelong devices.

The doctors must sign the document and confirm that the recipient was given an opportunity to review it before surgery. Companies that sell implants to doctors who don’t comply could face fines and other penalties from regulators. The rules begin to take effect in 30 days.

The rare form of cancer mentioned in this October 2021 article is likely breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare cancer of the immune system. BIA-ALCL has been closely linked with textured surface breast implants.

In addition to the new regulations, the FDA continues to maintain a registry where doctors can report cases of BIA-ALCL. The FDA has also updated the implant rupture screening recommendations for silicone gel-filled breast implants, as well as guidance for what manufacturers need to do with data collected from post-approval studies.

As always, we will continue to monitor the worldwide issues surrounding Biocell textured breast implants as well as other breast implants and BIA-ALCL. We will provide you with any new or relevant information.

We encourage you to visit our Breast Implants Lymphoma Cancer page on our website for more information. Please submit a free case evaluation if you or someone you know has been diagnosed with BIA-ALCL.

Written by: Lauren Schwab, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.


Breast Implants: Lymphoma / Blood Cancer Cases Overview

Free Breast Implants Case Evaluation

Filed Under: Unsafe Medical Devices Tagged With: breast implant cancer, breast implant-associated anaplastic large cell lymphoma, breast implants, breast implants BIA-ALCL, breast implants cancers, breast implants lymphoma cancers, textured breast implants

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.